FindTrial
Sign In

A Clinical trial comparing the effect of two drugs Levobupivacaine and ropivacaine in elective casarean section.

A Comparison between hyperbaric 0.5% levobupivacaine and hyperbaric 0.75% ropivacaine for spinal anesthesia in elective caesarean section. A prospective randomized double blinded study. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054695
Enrollment
60
Registered
2023-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Control Intervention1: HYPERBARIC 0.5% LEVOBUPIVACAINE: 2CC OF HYPERBARIC 0.5% LEVOBUPIVACAINE IS GIVEN ONCE INTRATHECALLY DURING SPINAL ANAESTHESIA. THE EFFECT OF DRUG WILL BE THERE FOR APPROXIMATELY

Sponsors

JSSAHER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults of ASA physical status II aged 18 to 40 years with gestational age between 37-42 weeks undergoing elective caesarean section.

Exclusion criteria

Exclusion criteria: Patient refusal Multiple pregnancy BMI > 30 Patients with known history of pregnancy induced hypertension, Gestational diabetes mellitus. • Spinal deformity • Bleeding disorder • Acute cardiovascular or respiratory disease • History of allergy or sensitivity to amide group of local anaesthetic • Psychiatric disease

Design outcomes

Primary

MeasureTime frame
Time of onset, maximum height and duration of sensory and motor blockade.Timepoint: STARTING FROM SPINAL ANAESTHESIA TILL 24 HOURS AFTER COMPLETION OF SURGERY—

Secondary

MeasureTime frame
a) To assess the hemodynamic status-Heart rate, Systolic blood pressure, Diastolic blood pressure, Mean arterial pressure b) To assess neonatal outcome (APGAR at 1min, 5min)Timepoint: STARTING FROM SPINAL ANAESTHESIA TILL 24 HOURS AFTER COMPLETION OF SURGERY—

Countries

India

Contacts

Public ContactDr Gurudutt C L

JSS Academy of Higher education and Research.

dattguru55@gmail.com9845312311

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026